HB 1236 Louisiana House · 2026 Regular Session

INSURANCE: Provides relative to pharmacy benefit managers reimbursements (EN +$2,265,844 SG EX See Note)

HB 1236 amends Louisiana laws governing pharmacy benefit manager reimbursements to establish a new payment formula based on claims data. This formula requires that reimbursement adjustments aim for a claim payment error rate of no more than two percent per drug. The bill also mandates that professional dispensing fees paid to pharmacists must be at least equal to the fee currently set by the Louisiana Department of Health for Medicaid. These changes directly affect pharmacy benefit managers and the state's Medicaid program by updating how they are compensated for dispensing medications.
Bill status signed all 5 stages cleared
Introduction
Apr 2026
Committee Review
May 2026
House Passage
Apr 2026
Senate Passage
May 2026
Signed into Law
Jun 2026
Introduced Apr 9, 2026 Signed Jun 12, 2026
Maddy AI version diff · 4 comparisons

What changed between versions

HB1236 Original HB1236 Act 913 · 8 edits
MODERATE
This bill updates Louisiana's pharmacy reimbursement laws to increase transparency and protect pharmacy profits from arbitrary adjustments by pharmacy benefit managers (PBMs). It mandates that PBMs use specific pricing benchmarks like NADAC or wholesale acquisition costs, requires a minimum professional dispensing fee based on actual pharmacy labor, and strictly prohibits PBMs from defining costs at their own discretion.
Scope change
The bill applies to all pharmacy benefit managers administering claims for health plans in Louisiana, with a specific exemption for the Office of Group Benefits.
REQUIREMENT

PBMs must adopt a reimbursement formula using NADAC or wholesale acquisition cost as the pricing benchmark, or an alternative approved by the commissioner that results in payment errors smaller than NADAC.

PBMs must use an adjustment factor based on claims experience data that is expected to result in a claim payment error rate of no more than two percent per drug.

PBMs must include a professional dispensing fee in their reimbursement formula that is at least equal to the fee established by the Louisiana Department of Health for Medicaid.

PBMs are prohibited from collecting, recouping, or recovering the professional dispensing fee from pharmacies, pharmacists, or members.

An appeal process must be established for pharmacists to challenge claim payment errors, requiring PBMs to include a written invoice from the wholesaler in the appeal.

DEFINITION

New definitions for 'Acquisition cost' and 'Professional dispensing fee' were added to clarify that acquisition costs are based on actual invoices and that professional fees must cover specific labor costs like counseling and filling.

The previous definition allowing PBMs to define acquisition costs at their sole discretion was removed.

TIMELINE

The effective date for these new PBM requirements was set to January 1, 2026.

Floor votes · Senate May 19, 2026 · House Apr 21, 2026

How they voted

340
Passed · 6 other
Total votes 40
May 19, 2026
D Democratic12
10 Yea 2
83% Yea
R Republican28
24 Yea 4
85% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
37
Key actions
14
Committee
14
May 31, 2026
Lower · Passed
Notice of Senate adoption of Conference Committee Report.
lower
May 31, 2026
Upper · Passed
Conference Committee Report read; adopted by a vote of 35 yeas and 0 nays.
upper
May 31, 2026
Upper · Passed
Notice House adopted the Conference Committee Report.
upper
May 31, 2026
Lower · Passed
Conference Committee Report read, roll called, yeas 93, nays 0. The Conference Committee Report was adopted.
lower
May 29, 2026
Lower · Passed
Conference Committee report received. Lies over under the rules.
lower
May 29, 2026
Upper · Passed
Conference committee report received.
upper
May 27, 2026
Upper · Passed
Notice House Conference Committee members appointed.
upper
May 26, 2026
Upper · Passed
Senate conference committee members appointed: Talbot, Bass, and Harris.
upper
May 19, 2026
Upper · Passed
Rules suspended. Read by title, passed by a vote of 34 yeas and 0 nays, and ordered returned to the House. Motion to reconsider tabled.
upper
May 12, 2026
Committee
Read by title and referred to the Legislative Bureau.
upper
May 11, 2026
Upper · Passed
Reported favorably.
upper
May 7, 2026
Committee
Read by title. Recommitted to the Committee on Finance.
upper
May 7, 2026
Upper · Passed
Senate Committee amendments read and adopted.
upper
May 6, 2026
Upper · Passed
Reported with amendments.
upper
Apr 21, 2026
Lower · Passed
Read third time by title, amended, roll called on final passage, yeas 102, nays 0. Finally passed, title adopted, ordered to the Senate.
lower
Apr 9, 2026
Lower · Passed
Read by title, substitute title adopted, lies over in the same order of business, substitute for HB No. 866 reported by the Committee on Insurance (12-0).
lower
1 primary · 1 co-sponsor

Sponsors